Aurotioprol is a gold salt used as an antirheumatic agent.[1][2]
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Intramuscular injection |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.043.971 |
Chemical and physical data | |
Formula | C3H6AuNaO4S2 |
Molar mass | 390.15 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
References
edit- ^ Perrier P, Raffoux C, Thomas P, Tamisier JN, Busson M, Gaucher A, Streiff F (September 1985). "HLA antigens and toxic reactions to sodium aurothiopropanol sulphonate and D-penicillamine in patients with rheumatoid arthritis". Annals of the Rheumatic Diseases. 44 (9): 621–4. doi:10.1136/ard.44.9.621. PMC 1001721. PMID 3876081.
- ^ Veys EM, Mielants H, Verbruggen G (1987). "Goldsalts, levamisole and D-penicillamine as first choice slow-acting antirheumatic drugs in rheumatoid arthritis--a long-term follow-up study". Clinical and Experimental Rheumatology. 5 (2): 111–6. PMID 3608266.